US 8609648
Hepatitis C virus inhibitors
granted A61KA61K31/437A61K31/4709
Quick answer
US patent 8609648 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/437, A61K31/4709, A61K31/496, A61K31/506